BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23088585)

  • 1. Haloarene derivatives of carbamazepine with reduced bioactivation liabilities: 2-monohalo and 2,8-dihalo derivatives.
    Elliott EC; Regan SL; Maggs JL; Bowkett ER; Parry LJ; Williams DP; Park BK; Stachulski AV
    J Med Chem; 2012 Nov; 55(22):9773-84. PubMed ID: 23088585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Bu HZ; Zhao P; Dalvie DK; Pool WF
    Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore.
    Graham EE; Walsh RJ; Hirst CM; Maggs JL; Martin S; Wild MJ; Wilson ID; Harding JR; Kenna JG; Peter RM; Williams DP; Park BK
    J Pharmacol Exp Ther; 2008 Aug; 326(2):657-71. PubMed ID: 18451316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
    Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
    Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation of lamotrigine in vivo in rat and in vitro in human liver microsomes, hepatocytes, and epidermal keratinocytes: characterization of thioether conjugates by liquid chromatography/mass spectrometry and high field nuclear magnetic resonance spectroscopy.
    Chen H; Grover S; Yu L; Walker G; Mutlib A
    Chem Res Toxicol; 2010 Jan; 23(1):159-70. PubMed ID: 19961160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel glutathione conjugates of terbinafine in liver microsomes and hepatocytes across species.
    Patil A; Ladumor MK; Kamble SH; Johnson BM; Subramanian M; Sinz MW; Singh DK; Putlur S; Bhutani P; Ahire DS; Singh S
    Xenobiotica; 2019 Dec; 49(12):1403-1413. PubMed ID: 30747549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of multiple glutathione conjugates of 8-amino- 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline maleate (nomifensine) in liver microsomes and hepatocyte preparations: evidence of the bioactivation of nomifensine.
    Yu J; Mathisen DE; Burdette D; Brown DG; Becker C; Aharony D
    Drug Metab Dispos; 2010 Jan; 38(1):46-60. PubMed ID: 19812352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carbamazepine on hepatic glutathione level in rats and determination of carbamazepine and its epoxide metabolite in plasma by HPLC.
    Yeşilaltay AK; Ersoy O; Omurtag GZ; Yurdun T
    Drug Metabol Drug Interact; 1998; 14(4):251-8. PubMed ID: 10694932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.
    Wen B; Coe KJ; Rademacher P; Fitch WL; Monshouwer M; Nelson SD
    Chem Res Toxicol; 2008 Dec; 21(12):2393-406. PubMed ID: 19548358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.
    Pearce RE; Lu W; Wang Y; Uetrecht JP; Correia MA; Leeder JS
    Drug Metab Dispos; 2008 Aug; 36(8):1637-49. PubMed ID: 18463198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver.
    Masubuchi Y; Nakano T; Ose A; Horie T
    Arch Toxicol; 2001 Nov; 75(9):538-43. PubMed ID: 11760814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites and DNA-binding of carbamazepine and oxcarbazepine in vitro by rat liver microsomes.
    Castrén K; Pienimäki P; Arvela P; Vähäkangas K
    Hum Exp Toxicol; 1996 Jul; 15(7):577-82. PubMed ID: 8818711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms.
    Xu L; Woodward C; Khan S; Prakash C
    Drug Metab Dispos; 2012 Apr; 40(4):680-93. PubMed ID: 22217465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.
    Alvarez-Sanchez R; Montavon F; Hartung T; Pähler A
    Chem Res Toxicol; 2006 Aug; 19(8):1106-16. PubMed ID: 16918252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of luteolin in primary rat hepatocytes: the role of CYP3A-mediated ortho-benzoquinone metabolite formation and glutathione depletion.
    Shi F; Zhao P; Li X; Pan H; Ma S; Ding L
    J Appl Toxicol; 2015 Nov; 35(11):1372-80. PubMed ID: 25612170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro.
    Tybring G; von Bahr C; Bertilsson L; Collste H; Glaumann H; Solbrand M
    Drug Metab Dispos; 1981; 9(6):561-4. PubMed ID: 6120817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fatty acid alpha-oxidation by rat hepatocytes and by liver microsomes fortified with NADPH, Fe3+ and phosphate.
    Huang S; Van Veldhoven PP; Asselberghs S; Eyssen HJ; de Hoffmann E; Mannaerts GP
    Lipids; 1994 Oct; 29(10):671-8. PubMed ID: 7861933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites.
    Kostrubsky SE; Strom SC; Ellis E; Nelson SD; Mutlib AE
    Chem Res Toxicol; 2007 Oct; 20(10):1503-12. PubMed ID: 17900172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.